Revive Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Revive Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Revive Therapeutics's Price has grown by 100.00%, rising from C$0.00 to C$0.00. For next year, analysts predict Fair Value of C$0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Revive Therapeutics's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XENE Stock Forecast | Xenon Pharmaceuticals | Buy |
11
|
$40.31 | Buy/Sell | $51.46 | 48.85% |
| ZYME Stock Forecast | Zymeworks | Outperform |
7
|
$8.67 | Buy/Sell | $13.52 | 61.48% |
| AUPH Stock Forecast | Aurinia Pharmaceuticals | Outperform |
6
|
$4.81 | Buy/Sell | $13.21 | 107.90% |
| EPIX Stock Forecast | ESSA Pharma | Buy |
5
|
$6.72 | Buy/Sell | $26.91 | 241.67% |
| ACHF.F Stock Forecast | Arch Biopartners | - |
4
|
$1.12 | Buy/Sell | $0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SVA Stock Forecast | Sernova | Outperform |
5
|
C$0.45 | Buy/Sell | C$4.07 | 655.56% |
| CRDL Stock Forecast | Cardiol Therapeutics | Outperform |
7
|
C$2.34 | Buy/Sell | C$4.50 | 92.31% |
| MIST Stock Forecast | Milestone Pharmaceuticals | Outperform |
4
|
$1.63 | Buy/Sell | $10.80 | 329.45% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDNA Stock Forecast | Medicenna Therapeutics | Buy |
0
|
C$1.67 | Buy/Sell | C$6.30 | 438.92% |
| IPA Stock Forecast | ImmunoPrecise Antibodies | Buy |
9
|
$1.24 | Buy/Sell | $7.00 | 464.52% |
| BCT Stock Forecast | BriaCell Therapeutics | Outperform |
4
|
C$2.95 | Buy/Sell | C$0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PMN Stock Forecast | ProMIS Neurosciences | Buy |
6
|
$2.00 | Buy/Sell | $18.49 | 497.00% |
| APS Stock Forecast | Aptose Biosciences | Outperform |
9
|
C$1.75 | Buy/Sell | C$11.08 | -100.00% |
| MBX Stock Forecast | Microbix Biosystems | Buy |
0
|
C$0.43 | Buy/Sell | C$0.00 | 86.05% |
Revive Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
Revive Therapeutics's EBITDA has seen impressive growth In the last three years, rising from C$-3.68M to C$-5.52M – a growth of 50.00%. In the next year, analysts believe that EBITDA will reach C$-8.23M – an increase of 49.03%. For the next seven years, the forecast is for EBITDA to grow by 187.90%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IBT Stock Forecast | IBEX Technologies | - |
0
|
C$1.44 | Buy/Sell | C$0.70 | -100.00% |
| TBPM.Q Stock Forecast | Tetra Bio-Pharma | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| EDSA Stock Forecast | Edesa Biotech | Buy |
-17
|
$4.36 | Buy/Sell | $36.67 | 381.65% |
Revive Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Revive Therapeutics's EBIT has grown by 49.86%, rising from C$-3.69M to C$-5.53M. For the next year, analysts predict that EBIT will reach C$-8.23M – an increase of 48.85%. Over the next seven years, experts believe that Revive Therapeutics's EBIT will grow at a rate of 187.06%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BU Stock Forecast | Burcon NutraScience | - |
0
|
C$0.22 | Buy/Sell | C$2.50 | -100.00% |
| COV Stock Forecast | Covalon Technologies | - |
0
|
C$1.01 | Buy/Sell | C$0.00 | -100.00% |
| 20B Stock Forecast | Biomark Diagnostics | - |
0
|
0.17€ | Buy/Sell | 0.00€ | -100.00% |
Revive Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Revive Therapeutics's EPS has grown by 100.00%, rising from C$-0.09 to C$0.00. For next year, analysts predict EPS of C$0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Revive Therapeutics's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SBM Stock Forecast | Sirona Biochem | - |
-10
|
C$0.07 | Buy/Sell | C$0.95 | -100.00% |
| RVX Stock Forecast | Resverlogix | - |
0
|
C$0.07 | Buy/Sell | C$0.00 | -100.00% |
| WLLW Stock Forecast | Willow Biosciences | - |
0
|
C$0.09 | Buy/Sell | C$2.00 | -100.00% |
.jpg)